Skip to main content
Log in

Abdominal obesity increases overnight cortisol excretion

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Although plasma and 24 h urinary free cortisol (UFC) levels are normal in obese subjects, pharmacological investigations have identified minor hypothalamo-pituitary-adrenal axis differences in patients with abdominal body fat distribution (A-BFD) vs peripheral BFD (P-BFD). Using recent tools such as saliva cortisol or overnight urinary free cortisol upon creatinine ratio (UFC/UC) determinations, we have investigated a population of obese females according to their body fat distribution. In-patients subjects (no.=82) were subjected to routine biochemical testing, 24 h and overnight UFC/UC, basal and post-1mg overnight dexamethasone-suppressing test plasma and saliva cortisol determinations. Central obesity defined by a waist-to-hip ratio (WHR) >0.85 was found in 64% of the subjects vs 87% when defined by waist girth (WG) corrected for age. Despite identical body mass index, A-BFD subjects were more prone to hypertension using both classifications and had higher triglycerides (WHR classification) or higher triglycerides, cholesterol and glycemia (WG classification). Plasma cortisol levels were similar but saliva cortisol levels were lower in the A-BFD group using the WG classification. The 24 h UFC/UC were similar but the overnight UFC/UC were higher in the A-BFD group using the WHR classification. These mild differences in cortisol nocturnal secretion and free cortisol indexes in subjects with different body fat mass distribution suggest that their hypothalamo-pituitaryadrenal axis has a spontaneously subtly different regulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Strain G.W., Zumoff B., Strain J.J., Levin J., Fukushima D.K. Cortisol production in obesity. Metabolism 1980, 29: 980.

    Article  CAS  PubMed  Google Scholar 

  2. Pasquali R., Cantobelli S., Casimirri F., Capelli M., Bortoluzzi L., Flamia R., Labate A.M.M., Barbara L. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab. 1993, 77: 341.

    CAS  PubMed  Google Scholar 

  3. Weaver J.U., Kopelman P.G., McLoughlin L., Forsling M.L., Grossman A. Hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity: a study of ACTH, AVP, β-lipotrophin and cortisol responses to insulin-induced hypoglycaemia. Clin. Endocrinol. (Oxf.) 1993, 39: 345.

    Article  CAS  Google Scholar 

  4. Björntrop P. Metabolic implications of body fat distribution. Diabetes Care 1991, 14: 1132.

    Article  Google Scholar 

  5. Björntrop P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 1991, 13: 795.

    Article  Google Scholar 

  6. Boushaki F.Z., Rasio E., Serri O. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine. Clin. Endocrinol (Oxf.) 1997, 46: 461.

    Article  CAS  Google Scholar 

  7. Mårin P., Darin N., Amemiya T., Andersson B., Jern S., Björntrop P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992, 41: 882.

    Article  PubMed  Google Scholar 

  8. Hautanen A., Adlercreutz H. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J. Intern. Med. 1993, 234: 461.

    Article  CAS  PubMed  Google Scholar 

  9. Pasquali R., Biscotti D., Spinucci G., Vicennati V., Genazzani A.D., Sgarbi L., Casimirri F. Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution. Clin. Endocrinol. (Oxf.) 1998, 48: 603.

    Article  CAS  Google Scholar 

  10. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr. Rev. 1990, 11: 80.

    Article  CAS  PubMed  Google Scholar 

  11. Umeda T., Hiramatsu R., Iwaoka T., Shimada T., Miura F., Sato T. Use of saliva for monitoring unbound free cortisol levels in serum. Clin. Chim. Acta 1981, 110: 245.

    Article  CAS  PubMed  Google Scholar 

  12. Corcuff J.-B., Tabarin A., Rashedi M., Duclos M., Roger P., Ducassou D. Overnight urinary free cortisol determination: a screening test for Cushing’s syndrome. Clin. Endocrinol. (Oxf.) 1998, 48: 503.

    Article  CAS  Google Scholar 

  13. Migeon C.J., Green O.C., Eekert J.P. Study of adrenocortical function in obesity. Metabolism 1963, 12: 718.

    CAS  PubMed  Google Scholar 

  14. Radloff L.S. The CES-D scale: a self report depression scale for research in the general population. Appl. Psych. Meas. 1997, 1: 385.

    Article  Google Scholar 

  15. World Health Organization. Measuring obesity-classification and description of anthropometric data Report on a WHO consultation of the epidemiology of obesity. Copenhagen, Denmark, Nutrition Unit, WHO, EUR/HFA, 1989.

    Google Scholar 

  16. Lemieux S., Prudhomme D., Bouchard C., Tremblay A., Despres J.P. Single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose-tissue. Am. J. Clin. Nutr. 1996, 64: 685.

    CAS  PubMed  Google Scholar 

  17. Taylor R.W., Keil D., Gold E.J., Williams S.M., Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am. J. Clin. Nutr. 1998, 67: 44.

    CAS  PubMed  Google Scholar 

  18. Crapo L. Cushing’s syndrome: a review of diagnostic tests. Metabolism 1979, 28: 955.

    Article  CAS  PubMed  Google Scholar 

  19. Cronin C., Igoe D., Duffy M.J., Cunningham S.K.K., McKenna T.J. The morning dexamethasone test is a worthwhile screening procedure. Clin. Endocrinol. (Oxf.) 1990, 33: 27.

    Article  CAS  Google Scholar 

  20. Edelstein C.K., Roybyrne P., Fawzy F.I., Dornfeld L. Effects of weight-loss on the dexamethasone suppression test. Am. J. Psych. 1983, 140: 338.

    CAS  Google Scholar 

  21. Yanovski S.Z., Yanovski J.A., Gwirtsman H.E., Bernat A., Gold P.W., Chrousos G.P. Normal dexamethasone suppression in obese binge and nonbinge eaters with rapid weight loss. J. Clin. Endocrinol. Metab. 1993, 76: 675.

    CAS  PubMed  Google Scholar 

  22. Ljung T., Andersson B., Bengtsson B.A., Björntrop P., Mårin P. Inhibition of cortisol secretion by dexamethasone in relation to body-fat distribution — a dose-response study. Obesity Res. 1996, 4: 277.

    Article  CAS  Google Scholar 

  23. Huizenga N.A.T.M., Koper J.W., De Lange P., Pols H.A.P., Stolk R.P., Grobbee D.E., De Jong F.H., Lamberts S.W.J. Interperson variability but intraperson stability of baseline cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitaryadrenal axis to a low dose of dexamethasone in elderly individuals. J. Clin. Endocrinol. Metab. 1998, 83: 47.

    CAS  PubMed  Google Scholar 

  24. Bujalska I.J., Kumar S., Stewart P.M. Does central obesity reflect „Cushing’s disease of the omentum”? Lancet 1997, 349: 1210.

    Article  CAS  PubMed  Google Scholar 

  25. Rissanen P., Hamalainen P., Vanninen E., Tenhunen-Eskelinen M., Uusitupa M. Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy X-ray absorptiometry in obese middle-aged women. Int. J. Obes. Relat. Metab. Disord. 1997, 21: 367.

    Article  CAS  PubMed  Google Scholar 

  26. Hauner H., Entenmann G., Wabitsch M., Gaillard D., Ailhaud G., Negrel R., Pfeiffer E.F. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin. Invest. 1989, 84: 1663.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Buemann B., Vohl M.C., Chagnon M., Chagnon Y.C., Gagnon J., Perusse L., Dionne F., Despres J.P., Tremblay A., Nadeau A., Bouchard C. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obesity Res. 1995, 5: 186.

    Article  Google Scholar 

  28. Hautanen A., Räikkönen K., Adlercreutz H. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinemia and dyslipidemia in normotensive males. J. Intern. Med. 1997, 241: 451.

    Article  CAS  PubMed  Google Scholar 

  29. Korbonits M., Trainer P.J., Nelson M.L., Howse I., Kopelman P.G., Besser G.M., Grossman A.B., Svec F. Differential stimulation of cortisol and dehydroepiandrosterone levels by food in obese and normal subjects: relation to body fat distribution. Clin. Endocrinol. (Oxf.) 1996, 45: 699.

    Article  CAS  Google Scholar 

  30. Rosmond R., Dallman M.F., Björntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 1998, 83: 1853.

    CAS  PubMed  Google Scholar 

  31. Wang C.N., McLeod R.S., Yao Z., Brindley D.N. Effects of dexamethasone on the synthesis, degradation and secretion of apolipoprotein B in cultured rat hepatocytes. Arterioscler. Thromb. Vasc. Biol. 1995, 15: 1481.

    Article  CAS  PubMed  Google Scholar 

  32. Reaven G. Banting lecture: role of insulin resistance in human disease. Diabetes 1988, 37: 1595.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Duclos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duclos, M., Corcuff, JB., Etcheverry, N. et al. Abdominal obesity increases overnight cortisol excretion. J Endocrinol Invest 22, 465–471 (1999). https://doi.org/10.1007/BF03343591

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343591

Key-words

Navigation